Sabra Health Care REIT, Inc. (SBRA) Revenue History
Annual and quarterly revenue from 2010 to present
SBRA Revenue Over Time (2010–2025)
SBRA Revenue Growth History
13 of 15 years with positive growth- FY2010 revenue growth
- N/A
- FY2011 revenue growth
- +857.1%
- FY2012 revenue growth
- +22.5%
- FY2013 revenue growth
- +30.6%
- FY2014 revenue growth
- +36.2%
- FY2015 revenue growth
- +30.2%
- FY2016 revenue growth
- +9.1%
- FY2017 revenue growth
- +55.7%
- FY2018 revenue growth
- +53.7%
- FY2019 revenue growth
- +7.2%
- FY2020 revenue growth
- -10.4%
- FY2021 revenue growth
- -4.8%
- FY2022 revenue growth
- +9.7%
- FY2023 revenue growth
- +3.6%
- FY2024 revenue growth
- +8.6%
- FY2025 revenue growth
- +10.2%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $221.8M | +20.8% |
| Q4 2025 | $211.9M | +16.2% |
| Q3 2025 | $190.0M | +6.8% |
| Q2 2025 | $189.2M | +7.4% |
| Q1 2025 | $183.5M | +10.1% |
| Q4 2024 | $182.3M | +11.6% |
| Q3 2024 | $178.0M | +10.6% |
| Q2 2024 | $176.1M | +9.7% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
SBRA's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
SBRA Revenue Analysis (2010–2025)
Current Revenue & Growth
As of June 21, 2026, Sabra Health Care REIT, Inc. (SBRA) generated trailing twelve-month (TTM) revenue of $812.8 million, reflecting exceptional growth of +20.8% year-over-year. The most recent quarter (Q1 2026) recorded $221.8 million in revenue, up 4.6% sequentially.
Historical Growth Trajectory
SBRA's 5-year compound annual growth rate (CAGR) stands at +5.3%, indicating steady revenue expansion. The 3-year CAGR of +7.4% exceeds the 5-year average, indicating an acceleration in the most recent period. Sabra Health Care REIT, Inc.'s highest annual revenue of $774.6 million was recorded in 2025, an all-time high.
Revenue by Segment
SBRA's revenue is primarily driven by Health Care, Resident Service, Ancillary Service (100%). With over half of revenue concentrated in Health Care, Resident Service, Ancillary Service, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Real Estate sector peers — including WELL (+38.3% YoY), VTR (+20.7% YoY), and OHI (+14.2% YoY) — SBRA has underperformed the peer group in revenue growth. Compare SBRA vs WELL →
SBRA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SBRACurrent | $813M | +20.8% | +5.3% | 34.1% | |
 WELL | $10.7B | +38.3% | +18.4% | 3.3% | |
 VTR | $5.8B | +20.7% | +9.0% | 14.2% | |
 OHI | $1.2B | +14.2% | +6.1% | 62.6% | |
 LTC | $263M | +49.1% | +10.5% | 48.2% | |
 CTRE | $477M | +90.0% | +22.1% | 67.2% |
SBRA Historical Revenue Data (2010–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $774.6M | +10.2% | $503.5M | 65.0% | $263.9M | 34.1% |
| 2024 | $703.2M | +8.6% | $476.1M | 67.7% | $257.0M | 36.5% |
| 2023 | $647.5M | +3.6% | $452.3M | 69.8% | $221.7M | 34.2% |
| 2022 | $624.8M | +9.7% | $462.2M | 74.0% | $234.8M | 37.6% |
| 2021 | $569.5M | -4.8% | $428.3M | 75.2% | $210.7M | 37.0% |
| 2020 | $598.6M | -10.4% | $467.0M | 78.0% | $0 | - |
| 2019 | $668.2M | +7.2% | $558.5M | 83.6% | $527.6M | 79.0% |
| 2018 | $623.4M | +53.7% | $573.9M | 92.1% | $307.0M | 49.2% |
| 2017 | $405.6M | +55.7% | $387.8M | 95.6% | $224.4M | 55.3% |
| 2016 | $260.5M | +9.1% | $254.8M | 97.8% | $160.9M | 61.8% |
| 2015 | $238.9M | +30.2% | $236.3M | 98.9% | $136.5M | 57.1% |
| 2014 | $183.5M | +36.2% | $179.6M | 97.9% | $110.8M | 60.4% |
| 2013 | $134.8M | +30.6% | $134.8M | 100.0% | $85.1M | 63.1% |
| 2012 | $103.2M | +22.5% | $103.2M | 100.0% | $56.8M | 55.1% |
| 2011 | $84.2M | +857.1% | $84.2M | 100.0% | $43.2M | 51.2% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
16+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SBRA — Frequently Asked Questions
Quick answers to the most common questions about buying SBRA stock.
Is SBRA's revenue growth accelerating or slowing?
SBRA revenue growth is accelerating. TTM revenue reached $813M, up +20.8% year-over-year — ahead of the 5-year CAGR of +5.3%. This indicates the business is expanding faster than its historical baseline.
What is SBRA's revenue history from 2010 to 2026?
Sabra Health Care REIT, Inc. (SBRA) revenue history spans 2010 to 2026. TTM revenue as of 2026 is $813M, growing at +20.8% YoY. The 5-year CAGR is +5.3%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is SBRA's long-term revenue growth rate (CAGR)?
Sabra Health Care REIT, Inc.'s 5-year revenue CAGR of +5.3% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +20.8% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for SBRA.
Why does SBRA's quarterly revenue fluctuate?
SBRA quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Sabra Health Care REIT, Inc.'s revenue data from 2010 to 2026 shows full historical quarterly detail on this page.
How is SBRA's revenue distributed by segment?
SBRA reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does SBRA's revenue compare to industry peers?
Sabra Health Care REIT, Inc. (SBRA) with TTM revenue of $813M and +20.8% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.